-
1 Comment
Alexandria Real Estate Equities, Inc is currently in a long term uptrend where the price is trading 8.8% above its 200 day moving average.
From a valuation standpoint, the stock is 70.3% more expensive than other stocks from the Real Estate sector with a price to sales ratio of 11.0.
Alexandria Real Estate Equities, Inc's total revenue rose by 13.6% to $464M since the same quarter in the previous year.
Its net income has increased by 118.1% to $441M since the same quarter in the previous year.
Finally, its free cash flow fell by 2.6% to $174M since the same quarter in the previous year.
Based on the above factors, Alexandria Real Estate Equities, Inc gets an overall score of 3/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | US0152711091 |
| Sector | Real Estate |
| Industry | REIT - Office |
| Market Cap | 11B |
|---|---|
| PE Ratio | 95.15 |
| Target Price | 216.68 |
| Dividend Yield | 6.9% |
| Beta | 1.29 |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2025, Alexandria has a total market capitalization of $28.8 billion and an asset base in North America that includes 39.6 million RSF of operating properties and 4.0 million RSF of Class A/A+ properties undergoing construction. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for A6W.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
